Intraocular lens (IOL) design has continued to evolve since being introduced in 1949. We have seen an evolution not only in design, but also in material, optics, safety, and efficacy, among other ...
RxSight, a commercial-stage provider of post-cataract intraocular lens platform, announced terms for its IPO on Monday. The Aliso Viejo, CA-based company plans to raise $125 million by offering 7.4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback